Cargando…

A randomized prospective study comparing the efficacy of on-demand therapy versus continuous therapy for 6 months for long-term maintenance with omeprazole 20 mg in patients with gastroesophageal reflux disease in Japan

AIM: To assess the efficacy of continuous therapy (cont) and on-demand therapy (on-demand) as maintenance therapy for gastroesophageal reflux disease (GERD). METHODS: Patients with upper GI endoscopy (EGD)-proven GERD who completed 8 weeks of initial therapy were randomized to cont (omeprazole 20 mg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagahara, Akihito, Hojo, Mariko, Asaoka, Daisuke, Sasaki, Hitoshi, Watanabe, Sumio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Informa Healthcare 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4002634/ https://www.ncbi.nlm.nih.gov/pubmed/24444414 http://dx.doi.org/10.3109/00365521.2013.878380

Ejemplares similares

The Relationship between H. pylori Infection and Osteoporosis in Japan
por: Asaoka, Daisuke, et al.
Publicado: (2014)

Buccal Buspirone as add–on Therapy to Omeprazole Versus Omeprazole in Treatment of Gastroesophageal Reflux Diseases (GERD)
por: Abdi, Saeed, et al.
Publicado: (2020)

Upper Gastrointestinal Mucosal Injury and Symptoms in Elderly Low-Dose Aspirin Users
por: Shimada, Yuji, et al.
Publicado: (2015)

The relationship between Helicobacter pylori infection and reflux esophagitis and the long-term effects of eradication of Helicobacter pylori on reflux esophagitis
por: Hojo, Mariko, et al.
Publicado: (2021)

Risk factors for osteoporosis in Japan: is it associated with Helicobacter pylori?
por: Asaoka, Daisuke, et al.
Publicado: (2015)

Efficacy of a potassium-competitive acid blocker for improving symptoms in patients with reflux esophagitis, non-erosive reflux disease, and functional dyspepsia
por: Asaoka, Daisuke, et al.
Publicado: (2017)

Association of medications for lifestyle-related diseases with reflux esophagitis
por: Asaoka, Daisuke, et al.
Publicado: (2016)

Evaluation of symptomatic reflux esophagitis in proton pump inhibitor users
por: Asaoka, Daisuke, et al.
Publicado: (2019)

Electrolyte disturbances in children receiving omeprazole for gastroesophageal reflux disease
por: Famouri, Fatemeh, et al.
Publicado: (2020)

Gastroesophageal Reflux Disease Relief in Patients Treated with Rabeprazole 20 mg versus Omeprazole 20 mg: A Meta-Analysis
por: Xia, X. M., et al.
Publicado: (2013)

A Systematic Review of the Effectiveness of Antianxiety and Antidepressive Agents for Functional Dyspepsia
por: Hojo, Mariko, et al.
Publicado: (2017)

A Randomized, Double Blinded, Clinical Trial to Assess the Efficacy and Cost Effectiveness of Omeprazole Compared to Rabeprazole in the Maintenance Therapy of Patients With Gastroesophageal Reflux Disease
por: Park, Jung Ho, et al.
Publicado: (2013)

Rectal Omeprazole in Infants With Gastroesophageal Reflux Disease: A Randomized Pilot Trial
por: Bestebreurtje, Petra, et al.
Publicado: (2020)

Prevalence of Gastroesophageal Reflux in Cats During Anesthesia and Effect of Omeprazole on Gastric pH
por: Garcia, R.S., et al.
Publicado: (2017)

Strategies for discontinuation of proton pump inhibitors (PPIs) in patients with long-term PPI administration: a randomized controlled trial
por: Hojo, Mariko, et al.
Publicado: (2022)

Effect of a Combination of Omeprazole Plus Sustained Release Baclofen Versus Omeprazole Alone on Symptoms of Patients with Gastroesophageal Reflux Disease (GERD)
por: Abbasinazari, Mohammad, et al.
Publicado: (2014)

On-demand versus half-dose continuous therapy with esomeprazole for maintenance treatment of gastroesophageal reflux disease: A randomized comparative study
por: Cho, Joon Hyun, et al.
Publicado: (2018)

Comparing the Effect of Psyllium Seed on Gastroesophageal Reflux Disease With Oral Omeprazole in Patients With Functional Constipation
por: Hosseini, Mousalreza, et al.
Publicado: (2018)

Esophageal Acidification During Nocturnal Acid-breakthrough with Ilaprazole Versus Omeprazole in Gastroesophageal Reflux Disease
por: Karyampudi, Arun, et al.
Publicado: (2017)

Omeprazole Treatment Failure in Gastroesophageal Reflux Disease and Genetic Variation at the CYP2C Locus
por: Kee, Ping Siu, et al.
Publicado: (2022)

Endoscopic anti-reflux therapy for gastroesophageal reflux disease
por: Rodríguez de Santiago, Enrique, et al.
Publicado: (2021)

Efficacy of the four weeks treatment of omeprazole plus mosapride combination therapy compared with that of omeprazole monotherapy in patients with proton pump inhibitor-refractory gastroesophageal reflux disease: a randomized controlled trial
por: Sirinawasatien, Apichet, et al.
Publicado: (2019)

Gaviscon(® )vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial
por: Pouchain, Denis, et al.
Publicado: (2012)

Linked color imaging improves visibility of reflux esophagitis
por: Takeda, Tsutomu, et al.
Publicado: (2020)

A prospective randomized trial of a potassium competitive acid blocker vs proton pump inhibitors on the effect of ulcer healing after endoscopic submucosal dissection of gastric neoplasia
por: Komori, Hiroyuki, et al.
Publicado: (2019)

Pharmacological Therapy of Gastroesophageal Reflux in Preterm Infants
por: Corvaglia, Luigi, et al.
Publicado: (2013)

Electrical Stimulation Therapy for Gastroesophageal Reflux Disease
por: Rinsma, Nicolaas F, et al.
Publicado: (2014)

Efficacy of vonoprazan for initial and maintenance therapy in reflux esophagitis, nonerosive esophagitis, and proton pump inhibitor-resistant gastroesophageal reflux disease
por: Gotoh, Yasuhiko, et al.
Publicado: (2020)

Randomized controlled study on the effects of triple therapy including vonoprazan or rabeprazole for the second-line treatment of Helicobacter pylori infection
por: Hojo, Mariko, et al.
Publicado: (2020)

Delayed-release oral suspension of omeprazole for the treatment of erosive esophagitis and gastroesophageal reflux disease in pediatric patients: a review
por: Monzani, Alice, et al.
Publicado: (2010)

A multicentre randomised trial to compare the efficacy of omeprazole versus rabeprazole in early symptom relief in patients with reflux esophagitis
por: Nagahara, Akihito, et al.
Publicado: (2013)

Randomized, multicenter study: on-demand versus continuous maintenance treatment with esomeprazole in patients with non-erosive gastroesophageal reflux disease
por: Bayerdörffer, Ekkehard, et al.
Publicado: (2016)

Omeprazole-Domperidone Fixed Dose Combination vs Omeprazole Monotherapy: A Phase 4, Open-Label, Comparative, Parallel Randomized Controlled Study in Mild to Moderate Gastroesophageal Reflux Disease
por: Marakhouski, KY, et al.
Publicado: (2017)

Optimization of Deep Sedation with Spontaneous Respiration for Therapeutic Endoscopy Combining Propofol and Bispectral Index Monitoring
por: Matsumoto, Kohei, et al.
Publicado: (2015)

Gut Microbiota Composition Before and After Use of Proton Pump Inhibitors
por: Hojo, Mariko, et al.
Publicado: (2018)

Obesity and gastroesophageal reflux disease and gastroesophageal reflux symptoms in children
por: Malaty, Hoda M, et al.
Publicado: (2009)

On-demand Versus Continuous Maintenance Treatment of Gastroesophageal Reflux Disease With Proton Pump Inhibitors: A Systematic Review and Meta-analysis
por: Kang, Seung Joo, et al.
Publicado: (2022)

Current perspectives on irritable bowel syndrome: a narrative review
por: Hojo, Mariko, et al.
Publicado: (2022)

Overlap Between Constipation and Gastroesophageal Reflux Disease in Japan: Results From an Internet Survey
por: Ogasawara, Naotaka, et al.
Publicado: (2022)

Factors associated with residual gastroesophageal reflux disease symptoms in patients receiving proton pump inhibitor maintenance therapy
por: Kawara, Fumiaki, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_m9pmqr56pjdmujto47oktfh909